<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02505074</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-P00015805</org_study_id>
    <nct_id>NCT02505074</nct_id>
  </id_info>
  <brief_title>Natural History of Melody Valve in the Mitral and Tricuspid Position</brief_title>
  <official_title>Natural History of Melody Valve in the Mitral and Tricuspid Position</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mount Sinai Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Children's Hospital and Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>NewYork Presbyterian Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Monroe Carell Jr. Children's Hospital at Vanderbilt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwell Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Primary Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Seattle Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Gruppo Ospedaliero San Donato</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Children's Hospital, Zurich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>IUCPQ et CHU de Quebec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital for Sick Kids</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Children’s Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Melody valve has historically been used for pulmonary valve replacements; however it has
      been more recently used in the mitral and tricuspid positions. This multi-center,
      retrospective, observational study will review the durability of the Melody valve inserted
      into the mitral or tricuspid positions.

      Patients who have undergone Melody valve insertion into either the mitral or tricuspid
      positions prior to December, 2014 will be eligible for the study. Basic de-identified patient
      demographics will be collected as well as select clinical data. Ventricular function and
      valvar function of the affected valve will be retrospectively reviewed both prior to surgery
      and following, as well as review of operative data. The investigators will also review the
      most recent follow up data and any subsequent re-interventions on the Melody valve. Data from
      all sites will be entered into an external REDCap database, using only de-identified data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prior to recent advancement in using the Melody valve for atrioventricular valve replacement,
      there have only been fixed diameter valve options for severe valve disease requiring
      replacement. This presents numerous obstacles for those pediatric patients who require
      replacement early in life, as the fixed diameter does not offer options for expansion for
      somatic growth, and early reoperation will be required.

      The Melody valve has been approved for transcatheter implantation into the RVOT (right
      ventricular outflow tract), and has shown competence within a range of sizes. Recent studies
      conducted at Boston Children's Hospital of off-label use of the Melody valve into
      atrioventricular valve positions have shown acceptable short-term valve performance, and that
      subsequent catheter-based expansion is feasible.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long term durability of Melody Valve in mitral and tricuspid positions, to be measured by degree of stenosis in Melody valve</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Long term durability of Melody Valve in mitral and tricuspid positions, to be measured by grade of regurgitation in Melody valve</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Long term durability of Melody Valve in mitral and tricuspid positions, to be measured by number of necessary re-interventions of Melody valve</measure>
    <time_frame>up to 5 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diseases of Mitral Valve</condition>
  <condition>Tricuspid Valve Disorder</condition>
  <arm_group>
    <arm_group_label>Mitral Valve Replacement</arm_group_label>
    <description>Review of retrospective data of those patients who have had surgical replacement of the mitral valve with the Melody valve.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tricuspid Valve Replacement</arm_group_label>
    <description>Review of retrospective data of those patients who have had surgical replacement of the tricuspid valve with the Melody valve.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Valve replacement with the Melody valve</intervention_name>
    <description>This study will only review patients who have had the Melody valve surgically inserted into the Mitral and/or Tricuspid positions. We will not be reviewing any other intervention type.</description>
    <arm_group_label>Mitral Valve Replacement</arm_group_label>
    <arm_group_label>Tricuspid Valve Replacement</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who have had a Melody valve inserted via surgical intervention prior to
        December, 2014, into either the mitral or tricuspid positions, will be eligible.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients who have had a Melody valve inserted into either mitral or tricuspid
             positions via surgical intervention

        Exclusion Criteria:

          -  There are no exclusion criteria.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sitaram Emani, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Surgeon</affiliation>
  </overall_official>
  <reference>
    <citation>Quiñonez LG, Breitbart R, Tworetsky W, Lock JE, Marshall AC, Emani SM. Stented bovine jugular vein graft (Melody valve) for surgical mitral valve replacement in infants and children. J Thorac Cardiovasc Surg. 2014 Oct;148(4):1443-9. doi: 10.1016/j.jtcvs.2013.10.059. Epub 2013 Dec 10.</citation>
    <PMID>24332108</PMID>
  </reference>
  <reference>
    <citation>Hasan BS, McElhinney DB, Brown DW, Cheatham JP, Vincent JA, Hellenbrand WE, Jones TK, Zahn EM, Lock JE. Short-term performance of the transcatheter Melody valve in high-pressure hemodynamic environments in the pulmonary and systemic circulations. Circ Cardiovasc Interv. 2011 Dec 1;4(6):615-20. doi: 10.1161/CIRCINTERVENTIONS.111.963389. Epub 2011 Nov 9.</citation>
    <PMID>22075926</PMID>
  </reference>
  <reference>
    <citation>Kaza AK, Lim HG, Dibardino DJ, Bautista-Hernandez V, Robinson J, Allan C, Laussen P, Fynn-Thompson F, Bacha E, del Nido PJ, Mayer JE Jr, Pigula FA. Long-term results of right ventricular outflow tract reconstruction in neonatal cardiac surgery: options and outcomes. J Thorac Cardiovasc Surg. 2009 Oct;138(4):911-6. doi: 10.1016/j.jtcvs.2008.10.058. Epub 2009 Jul 26.</citation>
    <PMID>19660342</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 29, 2015</study_first_submitted>
  <study_first_submitted_qc>July 20, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2015</study_first_posted>
  <last_update_submitted>February 27, 2018</last_update_submitted>
  <last_update_submitted_qc>February 27, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Boston Children’s Hospital</investigator_affiliation>
    <investigator_full_name>Sitaram Emani</investigator_full_name>
    <investigator_title>Cardiovascular Surgeon</investigator_title>
  </responsible_party>
  <keyword>mitral valve</keyword>
  <keyword>tricuspid valve</keyword>
  <keyword>Melody valve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

